MST PREVENTION - THE NORWAY EXPERIENCE

Authors
Citation
B. Straypedersen, MST PREVENTION - THE NORWAY EXPERIENCE, Contraception fertilite sexualite, 24(3), 1996, pp. 213-217
Citations number
13
Categorie Soggetti
Obsetric & Gynecology
ISSN journal
11651083
Volume
24
Issue
3
Year of publication
1996
Pages
213 - 217
Database
ISI
SICI code
1165-1083(1996)24:3<213:MP-TNE>2.0.ZU;2-J
Abstract
A significant decrease in the incidence of most STDs has been reported in Norway during the last decade, especially the last 5 years. Today, syphilis, hepatitis B and gonorrhoea are almost non-existent with inc idence rates (IR) of 1.1, 0.9 and 4.4 per 100 000 respectively. The fr equency of genital herpes, however, has remainded unchanged (IR = 45), while chlamydial infection has shown a decrease of 13% during the las t year (IR women = 240). The Chlamydia epidemic became evident in the early 1980-ies and since then has represented the major treat to the r eproductive condition in young women resulting in PID, tubal occlusion s and ectopic pregnancies. In Norway a preoperative screening program in connection with the performance of abortions was introduced 8-9 yea rs ago. Since then a gradual decrease in the frequency of chlamydial p ositivity has been notified. Art our hospital a reduction of 75% (from 11.7% to 3.1%) in the prevalence of C. trachomatis has been observed in women seeking abortion. The decrease is evident is all age groups, but predominantly in those below 25 years. At the same time the freque ncy of PID has decreased by 80%, while so far only a slight reduction in the frequency of ectopic pregnancies has been observed Public and p rofessional awareness, together with an increased prescription of anti -chlamydial drugs to women with genital infections may have contribute d to this decrease. Partner tracing is not satisfactory, being perform ed in only one out of 5 cases. A new act for the prevention of communi cable diseases will be introduced next year. This act will make partne r notification mandatory and STD treatment free of charge. In Norway 3 50 000 chlamydial tests (8 per 100 inhabitants) are performed per year , 39% in women < 25 years. Even today the age-specific prevalence of t hese women are so high that Chlamydia screening is cost-effective.